Most Read News


KPA & KPBMA discuss about counteractions on pharmas noncooperative to returns

The Korea Pharmaceutical Association(President Chan-Hwi Cho, KPA) and the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Sun-Hye Cho, KPBMA) created a consultative group to strengthen cooperati...

Total 23 doctors and pharmacists preregistered as candidates for 6.13 Local Election

8 pharmacists preregistered themselves as candidates at the National Election Commission for the upcoming local election on the 13th of June. Yakup Shinmoon(www.yakup.com) analyzed occupations that the candidates for...

Moon Jae-In’s completed tasks for the past 1 year

The Moon Jae-In administration announced finished tasks for the past 1 year, such as  R&D efficiency and the start of Moon Jae-In Care. The administration has also showed a will to export breakthrough medicines at th...

Pharmas active in developing antihypertensive combination drugs

Ever since the incrementally modified drug system was adopted in 2009, total 16 products were approved as a combination therapy for hypertension. Moreover, antihypertensives are reportedly moving towards a trend with...

Both joys and sorrows about operating profits in the pharmaceutical packaging equipment industry

Last year, pharmaceutical packaging equipment companies have faced different situations in business performance. Yakup Shinmoon(www.yakup.com) analyzed 2017 audit reports that 7 major drug packaging equipment compani...

‘Growing’ Korean health supplements market attracting the high value industry

The Korea Health Supplements Association(Chairman Seok-Hyung Kwon) announced the 2017 health supplements market structure by size, ingredient and distribution channel based on data from the health supplement purchasin...

Will Cyramza with health insurance benefits broaden options for stomach cancer patients?

Will ‘Cyramza(generic name: ramucirumab),’ a secondary treatment for stomach cancer, break the wall of health insurance benefits and become a practical treatment option for stomach cancer patients? Lilly Korea, on th...

Top 3 pharma distribution companies own 23% of total surpluses that the industry owns

Pharmaceutical distribution companies reportedly saved KRW 2.1 trillion external surpluses accumulated internally at the end of the last year. Especially, the top 3 companies, Geo-Young, UMC Holdings and Ohsong Pharm,...

Increase in OTC drug approval

The number of OTC drug approvals has increased since this year. The percentage of approvals for OTC drugs is reaching 27% by this April. According to the Ministry of Food and Drug Safety(MFDS) Online Library, there w...

Celltrion Healthcare starts to sell ‘Herzuma’ in Europe

Celltrion Healthcare announced on the 3rd that ‘Herzuma(generic name: trastuzumab),’ an antibody biosimilar for the treatment of breast cancer and stomach cancer, was first launched in the U.K. It is an early launch w...

TYLENOL may cause liver damages if taking more than 4,000mg a day

It was studied that drugs containing acetaminophen, such as analgesic/antipyretic TYLENOL, had a high chance to cause liver damages if being taken by patients with a volume higher than 4,000mg a day. Thus, approval d...

Employees at multinational pharma branches in Korea make KRW 76 million salary a year per

The average annual salary of employees working for multinational pharmaceutical companies’ branches was about KRW 76 million, and employees at GlaxoSmithKline were making the highest annual salary of KRW 131 million o...

One third of R&D expenses were spent into clinical studies in pharma industry

Pharmaceutical companies reportedly are spending 30% of their R&D expenses into the clinical study field. Moreover, they are also spending 13% into developing biologics which have recently brought various achievement...

Foreign pharmaceutical company branches sending a half of net profits to their headquarters

Multinational pharmaceutical companies branching in Korea reportedly sent a half of net profits to their overseas headquarters without being careless in social return of company profits to the Korean society. Yakup S...

‘Life-Prolonging Care Act’ will be upgraded this May

The Ministry of Health and Welfare(MOHW) will revise regulations in regards to the Life Prolonging Care Act this May. Activities which will be followed after to revise them are discussion about narrowing down the rag...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.